Published in J Alzheimers Dis on May 25, 2017
Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis (2014) 2.01
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial. Lancet Neurol (2014) 1.89
An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol Commun (2016) 1.45
Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts. Science (2016) 1.43
Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain. Mol Neurodegener (2016) 1.41
2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimers Dement (2015) 1.17
Association of diabetes with amnestic and nonamnestic mild cognitive impairment. Alzheimers Dement (2013) 1.13
Estimating long-term multivariate progression from short-term data. Alzheimers Dement (2014) 0.99
Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014. Alzheimers Dement (2015) 0.98
[18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration. Acta Neuropathol (2016) 0.95
Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers. Neurobiol Aging (2014) 0.94
Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies. Neurobiol Aging (2014) 0.89
Defining imaging biomarker cut points for brain aging and Alzheimer's disease. Alzheimers Dement (2016) 0.89
Mapping ventricular expansion onto cortical gray matter in older adults. Neurobiol Aging (2014) 0.87
The transitional association between β-amyloid pathology and regional brain atrophy. Alzheimers Dement (2014) 0.87
Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC-NCS). Alzheimers Dement (Amst) (2016) 0.86
Seemingly unrelated regression empowers detection of network failure in dementia. Neurobiol Aging (2014) 0.86
Working memory and language network dysfunctions in logopenic aphasia: a task-free fMRI comparison with Alzheimer's dementia. Neurobiol Aging (2014) 0.85
Performance of the CogState computerized battery in the Mayo Clinic Study on Aging. Alzheimers Dement (2015) 0.83
Diffusion tensor imaging comparison of progressive supranuclear palsy and corticobasal syndromes. Parkinsonism Relat Disord (2014) 0.82
Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population-based elderly cohort. Alzheimers Dement (2016) 0.82
Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size. Neurobiol Aging (2013) 0.81
Assessing atrophy measurement techniques in dementia: Results from the MIRIAD atrophy challenge. Neuroimage (2015) 0.81
Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging. Alzheimers Dement (2014) 0.80
Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort. Alzheimers Dement (2015) 0.80
Mediterranean diet, micronutrients and macronutrients, and MRI measures of cortical thickness. Alzheimers Dement (2016) 0.80
Drug development in Alzheimer's disease: the path to 2025. Alzheimers Res Ther (2016) 0.79
Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies. Neurobiol Aging (2014) 0.79
Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment. Neurobiol Aging (2014) 0.79
FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging. J Alzheimers Dis (2016) 0.78
Microbleeds in the logopenic variant of primary progressive aphasia. Alzheimers Dement (2013) 0.78
Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease. Alzheimers Dement (2016) 0.78
Language networks associated with computerized semantic indices. Neuroimage (2014) 0.78
TYROBP genetic variants in early-onset Alzheimer's disease. Neurobiol Aging (2016) 0.78
Excessive daytime sleepiness and fatigue may indicate accelerated brain aging in cognitively normal late middle-aged and older adults. Sleep Med (2016) 0.77
Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer's disease. Parkinsonism Relat Disord (2015) 0.77
Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition. J Alzheimers Dis (2016) 0.77
Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity. J Alzheimers Dis (2016) 0.77
Alzheimer's disease: The next frontier-Special Report 2017. Alzheimers Dement (2017) 0.76
Microbleeds in atypical presentations of Alzheimer's disease: a comparison to dementia of the Alzheimer's type. J Alzheimers Dis (2015) 0.76
Massachusetts Alzheimer's Disease Research Center: Progress and challenges. Alzheimers Dement (2015) 0.76
White matter integrity in dementia with Lewy bodies: a voxel-based analysis of diffusion tensor imaging. Neurobiol Aging (2015) 0.76
RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodies. Neurobiol Aging (2016) 0.76
Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiol Aging (2017) 0.75
MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies. Alzheimers Dement (2016) 0.75
Tracking the development of agrammatic aphasia: A tensor-based morphometry study. Cortex (2016) 0.75
Prospective associations of plasma phospholipids and mild cognitive impairment/dementia among African Americans in the ARIC Neurocognitive Study. Alzheimers Dement (Amst) (2016) 0.75
Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy. Parkinsonism Relat Disord (2016) 0.75
Comparison of Gait Parameters for Predicting Cognitive Decline: The Mayo Clinic Study of Aging. J Alzheimers Dis (2016) 0.75
Clinical and MRI models predicting amyloid deposition in progressive aphasia and apraxia of speech. Neuroimage Clin (2016) 0.75
An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease. Alzheimers Dement (2016) 0.75
Life-course blood pressure in relation to brain volumes. Alzheimers Dement (2016) 0.75
Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition. Alzheimers Dement (Amst) (2016) 0.75
Imaging markers of cerebrovascular pathologies: Pathophysiology, clinical presentation, and risk factors. Alzheimers Dement (Amst) (2016) 0.75
A robust biomarker of large-scale network failure in Alzheimer's disease. Alzheimers Dement (Amst) (2017) 0.75
Erratum to: Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain. Mol Neurodegener (2016) 0.75
Clinical and neuroimaging characteristics of clinically unclassifiable primary progressive aphasia. Brain Lang (2019) 0.75
Mayo Normative Studies: Regression-Based Normative Data for the Auditory Verbal Learning Test for Ages 30-91 Years and the Importance of Adjusting for Sex. J Int Neuropsychol Soc (2020) 0.75
Pittsburgh compound B (PiB) PET imaging of meningioma and other intracranial tumors. J Neurooncol (2017) 0.75
Erratum to: Prognosis of Patients with Behavioral Variant Frontotemporal Dementia Who have Focal Versus Diffuse Frontal Atrophy. J Clin Neurol (2017) 0.75
Association of Kidney Function Biomarkers with Brain MRI Findings: The BRINK Study. J Alzheimers Dis (2016) 0.75
White-matter integrity on DTI and the pathologic staging of Alzheimer's disease. Neurobiol Aging (2017) 0.75
The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement. Alzheimers Dement (2016) 0.75
Prognosis of Patients with Behavioral Variant Frontotemporal Dementia Who have Focal Versus Diffuse Frontal Atrophy. J Clin Neurol (2017) 0.75
Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials. Alzheimers Dement (2017) 0.75
Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study. J Alzheimers Dis (2015) 0.75
Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study. Lancet Neurol (2017) 0.75
TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. Nature (2022) 0.75
Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration. Brain (2019) 0.75
Association of Central Arterial Stiffness and Pressure Pulsatility with Mild Cognitive Impairment and Dementia: The Atherosclerosis Risk in Communities Study-Neurocognitive Study (ARIC-NCS). J Alzheimers Dis (2017) 0.75
Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study. Lancet Neurol (2017) 0.75
Phenoconversion from probable rapid eye movement sleep behavior disorder to mild cognitive impairment to dementia in a population-based sample. Alzheimers Dement (Amst) (2017) 0.75
Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies. Alzheimers Dement (Amst) (2019) 0.75
Uptake of AV-1451 in meningiomas. Ann Nucl Med (2017) 0.75
First PET Imaging Studies With 63Zn-Zinc Citrate in Healthy Human Participants and Patients With Alzheimer Disease. Mol Imaging (2016) 0.75
Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia. Brain (2017) 0.75
The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes. Brain (2019) 0.75
The biomarker-based diagnosis of Alzheimer's disease. 2-lessons from oncology. Neurobiol Aging (2017) 0.75